(Press-News.org) Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.
Dr Melanie Bahlo, Ms Katherine Smith and Ms Catherine Bromhead from the Walter and Eliza Hall Institute's Bioinformatics division, in collaboration with neurologist and epilepsy specialist Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, have found that mutations in the CLN6 gene on chromosome 15 are the cause of inherited recessive Kufs type A disease. The paper was published in the American Journal of Human Genetics.
Kufs disease is a rare but fatal, hereditary neurodegenerative disease usually identified in early adulthood. Brain symptoms result from a build up of fat in brain cells that is toxic to the cells, causing symptoms including epilepsy, dementia, impaired motor function and intellectual deterioration. It affects approximately 1 in 1,000,000 people.
Professor Berkovic, head of the Epilepsy Research Centre at the University of Melbourne and the Comprehensive Epilepsy Program at Austin Health, said identification of the CLN6 gene would enable more efficient and much less invasive techniques for earlier diagnosis of Kufs disease.
"Currently, the only way that we can reliably diagnose this disease is to do an invasive and dangerous brain biopsy, or at autopsy," Professor Berkovic said. "The discovery of the gene at the root of Kufs type A disease will enable us to use a rapid and simple blood test to genetically test for the disease. It will also give us the ability to screen for the disease in people in at-risk families, and make it possible for genetic counseling, which we already know to be very important for patients."
Dr Bahlo's and Ms Smith's innovative work used data generated from a person's DNA, called SNP genotyping. When combined with sophisticated mathematical and statistical analysis, the information helped them identify the region in the human genome likely to contain the DNA error that causes Kufs disease which led to discovery of the gene mutations.
"The genetic cause of Kufs disease has remained a mystery for over 25 years, because the rarity of the condition meant that our patient groups were so small we couldn't reliably pinpoint any particular genetic mutations that caused their disease," Dr Bahlo said. "In this study, we used an innovative suite of highly specialised techniques and statistical algorithms that compensated for the small sample size and allowed us to look at the entire genetic code of people with Kufs disease to find which region of the DNA had the mutation which caused disease. Discovering the CLN6 gene as the cause of Kufs disease is a great outcome for us and for the people who are affected by this awful disease."
Professor Berkovic said the best possible outcome from the study would be the development of a treatment for Kufs disease, which is currently untreatable and invariably fatal. "The general aim and hope of this work is always to be able to use the discovery to translate to a treatment, but this is still some time away," he said.
Professor Berkovic said that his team's collaboration with Dr Bahlo's bioinformatics group at the institute had produced several exciting results in a short time. This includes a number of important outcomes for epilepsy sufferers, with the genetic basis for four epilepsy-related diseases discovered in the past four years.
Dr Bahlo said that the innovative study used to find the gene responsible for Kufs disease could hold the key for finding the genetic cause of a number of other hereditary diseases including other epilepsy-related diseases, deafness and some familial cancers.
"These new techniques for using statistical data and mathematical algorithms to track down the genetic basis of disease are really at the forefront of medical research today," Dr Bahlo said. "Finding the genes responsible for certain diseases will help us in our quest to generate new diagnostic tools as well as provide the basis for fundamental biology that leads to development of new drugs and therapies to treat disease."
INFORMATION:
The work was supported by the National Health and Medical Research Council and the Batten Disease Support and Research Association.
New technology helps to find gene responsible for Kufs disease
2011-05-08
ELSE PRESS RELEASES FROM THIS DATE:
PCH Treatment Treats Panic Disorder
2011-05-08
The Psychological Care and Healing Treatment Center, the leading destination for people who want to have their psychological disorders fixed, now offers Panic Disorder treatment Clinic.
A Panic Disorder is considered as such when a person experiences several panic attacks within a short period of time. First of all, people must know that panic attacks are not very common. In fact, some people live their lives and experience only as little as two or three panic attacks through out their lives. This is why it is very uncommon to experience or suffer from several panic ...
Strong evidence supports prognostic value of circulating tumor cells in breast cancer
2011-05-08
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
At the IMPAKT Breast Cancer Conference in Brussels, Dr François-Clement Bidard and colleagues from Institut Curie in Paris say their new findings set the scene for interventional trials designed to see if improved outcomes can be achieved by modifying treatment based on circulating tumor cell counts.
"We needed to do this study to confirm data provided ...
Epigenetic study reveals new insights into breast cancer
2011-05-08
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.
Epigenetics is a term used to describe modifications to the DNA molecule that affect way its code is translated into proteins. These changes include methylation, a form of chemical modification.
Although researchers knew epigenetics was important in cancer, information about its exact contribution to breast carcinogenesis was scant, Dr Sarah Dedeurwaerder, from Université ...
Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer
2011-05-08
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.
Triple-negative breast cancers --which do not express the genes for estrogen receptor, or progesterone receptor and do not have Her2/neu overexpression or amplification-- are more aggressive than other forms of the disease and cannot be treated with endocrine or Her2 targeted therapies.
At the IMPAKT Breast Cancer Conference in Brussels, PhD student Carolin Huelsewig and Dr Cornelia Liedtke from Uniklinikum Muenster ...
Breast cancer multi-gene tests compared
2011-05-08
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
In recent years, several genomic tests have been developed to provide prognostic information for breast cancer. Dr Catherine Kelly from Mater Misericordiae University Hospital, Dublin, Ireland, and colleagues in the USA examined the agreement in prediction results between two multi-gene assays ...
Protein snapshots reveal clues to breast cancer outcomes
2011-05-08
Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies.
At the IMPAKT Breast Cancer Conference in Brussels, Dr Gargi Patel from the Richard Dimbleby Department, King's College London, described cutting-edge research in which she and colleagues captured detailed information about protein interactions on cancer cells, and correlated that with established genetic markers for cancer ...
Anti-inflammatory drug may fight breast cancer
2011-05-08
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
The results of a randomized trial in 45 patients with primary invasive breast cancer showed that the drug --which is currently used to treat arthritis and other painful conditions-- clearly induced an anti-tumor response at the molecular level.
"This is exciting because it means that a medication already used to treat other diseases may be efficient in the adjuvant treatment of breast cancer ...
Female-to-male transsexual people have more autistic traits
2011-05-08
Domenico Di Ceglie, Director of Training and Research at the Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust in London, commented: "These are important findings in the field of gender incongruence, which need to be replicated. The awareness of the presence of autistic features may help these young people to explore the reasons behind their perceptions, and help them make more informed decisions about treatment."
Emma Martin, who runs a Gender Identity Support and research group in Little Downham, UK, welcomed the new findings, and ...
New biosensor modelled on the immune system can detect, track and guide the clean-up of oil spills
2011-05-08
A new biosensor which uses antibody-based technology has been shown to detect marine pollutants such as oil cheaper and faster than current technology. Tests of the new biosensor, published in Environmental Toxicology and Chemistry, reveal how it could be used for the early detection and tracking of oil spills.
The biosensor has been developed by researchers at the Virginia Institute of Marine Science (VIMS) and was tested in the Elizabeth River and Yorktown Creek which both drain into Virginia's Chesapeake Bay.
"Our biosensor combines the power of the immune system ...
Spine Surgeon LA Launches New Website
2011-05-08
Spine Surgeon LA, the leading spine surgery specialists in the state of California has recently launched their website at the URL www.spinesurgeonla.com
Spine Surgeon LA is a medical hub wherein they treat and address several different types of spine problems. These spine problems include: Bulging Disc, Herniated Disc, Spine Scoliosis, Pinched Nerve, Spine Stenosis, Bone Spurs, and Spine Tumors among others. In their new website, spinesurgeonla.com, you may click on these common spine problems and then get a chance to read some information about them so that you may ...